Editorial Comment on: Efficacy and safety of TachoSil as haemostatic treatment versus standard suturing in kidney tumour resection: a randomised prospective study.
Sagalowsky
Arthur I
AI
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA. arthur.sagalowsky@utsouthwestern.edu
D002292:Carcinoma, Renal Cell / Q000601:surgery*; D004338:Drug Combinations; D005340:Fibrinogen / Q000009:adverse effects / Q000627:therapeutic use*; D006490:Hemostatics / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007680:Kidney Neoplasms / Q000601:surgery*; D012449:Safety; D015503:Surgical Sponges; D013537:Sutures; D013917:Thrombin / Q000009:adverse effects / Q000627:therapeutic use*
D004338:Drug Combinations; D006490:Hemostatics; C518955:TachoSil; D005340:Fibrinogen; D013917:Thrombin